Sixteen MassBio Member Companies Selected to Present at BioPharm America™ 2010 and the MassBio Investors Forum
Sixteen MassBio member companies were selected to present at BioPharm America™ 2010 and the MassBio Investors Forum being held Wednesday, September 15th at the Marriott Boston Copley Place.
In partnership with BioPharm America™, the MassBio Investors Forum will bring together companies from across the globe to partner and invest in Massachusetts most innovative companies. MassBio and EBD Group will make this combined North America’s premiere partnering events -- creating a unique, high powered business exchange that unites the international life sciences community.
The following companies will present at the event:
Acetylon Pharmaceuticals Inc. Boston
Anchor Therapeutics Cambridge
Cerulean Pharma Inc. Cambridge
Hepregen Corporation Medford
Merck & Co Boston
Mersana Therapeutics, Inc. Cambridge
NKT Therapeutics Waltham
Pfizer, Inc. Cambridge
Pro-Pharmaceuticals, Inc. Newton
Rxi Pharmaceuticals Worcester
Taligen Therapeutics Cambridge
The company presentations compliment panel discussions, keynote speakers and one-on-one partnering meetings all taking place at BioPharm America ™ 2010.
For more information about the conference, visit www.ebdgroup.com/bpa.